The metalloprotease disintegrin ADAM8 - Processing by autocatalysis is required for proteolytic activity and cell adhesion

Schlomann U, Wildeboer D, Webster A, Antropova O, Zeuschner D, Knight CG, Docherty AJP, Lambert M, Skelton L, Jockusch H, Bartsch JW (2002)
Journal of Biological Chemistry 277(50): 48210-48219.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ; ; ; ; ; ;
Abstract / Bemerkung
ADAMs (a disintegrin and metalloprotease domains) are metalloprotease and disintegrin domain-containing transmembrane glycoproteins with proteolytic, cell adhesion, cell fusion, and cell signaling properties. ADAM8 was originally cloned from monocytic cells, and its distinct expression pattern indicates possible roles in both immunology and neuropathology. Here we describe our analysis of its biochemical properties. In transfected COS-7 cells, ADAM8 is localized to the plasma membrane and processed into two forms derived either by prodomain removal or as remnant protein comprising the extracellular region with the disintegrin domain at the N terminus. Proteolytic removal of the ADAM8 propeptide was completely blocked in mutant ADAM8 with a Glu(330) to Gln exchange (EQ-A8) in the Zn2+ binding motif (HE(330)LGHNLGMSHD), arguing for autocatalytic prodomain removal. In co-transfection experiments, the ectodomain but not the entire MP domain of ADAM8 was able to remove the prodomain from EQ-ADAM8. With cells expressing ADAM8, cell adhesion to a substrate-bound recombinant ADAM8 disintegrin/Cys-rich domain was observed in the absence of serum, blocked by an antibody directed against the ADAM8 disintegrin domain. Soluble ADAM8 protease, consisting of either the metalloprotease domain or the complete ectodomain, cleaved myelin basic protein and a fluorogenic peptide substrate, and was inhibited by batimastat (BB-94, IC50 similar to50 nM) but not by recombinant tissue inhibitor of matrix metalloproteinases 1, 2, 3, and 4. Our findings demonstrate that ADAM8 processing by autocatalysis leads to a potential sheddase and to a form of ADAM8 with a function in cell adhesion.
Erscheinungsjahr
Zeitschriftentitel
Journal of Biological Chemistry
Band
277
Ausgabe
50
Seite(n)
48210-48219
ISSN
eISSN
PUB-ID

Zitieren

Schlomann U, Wildeboer D, Webster A, et al. The metalloprotease disintegrin ADAM8 - Processing by autocatalysis is required for proteolytic activity and cell adhesion. Journal of Biological Chemistry. 2002;277(50):48210-48219.
Schlomann, U., Wildeboer, D., Webster, A., Antropova, O., Zeuschner, D., Knight, C. G., Docherty, A. J. P., et al. (2002). The metalloprotease disintegrin ADAM8 - Processing by autocatalysis is required for proteolytic activity and cell adhesion. Journal of Biological Chemistry, 277(50), 48210-48219. doi:10.1074/jbc.M203355200
Schlomann, U., Wildeboer, D., Webster, A., Antropova, O., Zeuschner, D., Knight, C. G., Docherty, A. J. P., Lambert, M., Skelton, L., Jockusch, H., et al. (2002). The metalloprotease disintegrin ADAM8 - Processing by autocatalysis is required for proteolytic activity and cell adhesion. Journal of Biological Chemistry 277, 48210-48219.
Schlomann, U., et al., 2002. The metalloprotease disintegrin ADAM8 - Processing by autocatalysis is required for proteolytic activity and cell adhesion. Journal of Biological Chemistry, 277(50), p 48210-48219.
U. Schlomann, et al., “The metalloprotease disintegrin ADAM8 - Processing by autocatalysis is required for proteolytic activity and cell adhesion”, Journal of Biological Chemistry, vol. 277, 2002, pp. 48210-48219.
Schlomann, U., Wildeboer, D., Webster, A., Antropova, O., Zeuschner, D., Knight, C.G., Docherty, A.J.P., Lambert, M., Skelton, L., Jockusch, H., Bartsch, J.W.: The metalloprotease disintegrin ADAM8 - Processing by autocatalysis is required for proteolytic activity and cell adhesion. Journal of Biological Chemistry. 277, 48210-48219 (2002).
Schlomann, U, Wildeboer, D, Webster, A, Antropova, O, Zeuschner, D, Knight, CG, Docherty, AJP, Lambert, M, Skelton, L, Jockusch, Harald, and Bartsch, JW. “The metalloprotease disintegrin ADAM8 - Processing by autocatalysis is required for proteolytic activity and cell adhesion”. Journal of Biological Chemistry 277.50 (2002): 48210-48219.

74 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

ADAM9 contributes to vascular invasion in pancreatic ductal adenocarcinoma.
Oria VO, Lopatta P, Schmitz T, Preca BT, Nyström A, Conrad C, Bartsch JW, Kulemann B, Hoeppner J, Maurer J, Bronsert P, Schilling O., Mol Oncol 13(2), 2019
PMID: 30556643
Fine Tuning Cell Migration by a Disintegrin and Metalloproteinases.
Dreymueller D, Theodorou K, Donners M, Ludwig A., Mediators Inflamm 2017(), 2017
PMID: 28260841
SheddomeDB: the ectodomain shedding database for membrane-bound shed markers.
Tien WS, Chen JH, Wu KP., BMC Bioinformatics 18(suppl 3), 2017
PMID: 28361715
IL-5-stimulated eosinophils adherent to periostin undergo stereotypic morphological changes and ADAM8-dependent migration.
Johansson MW, Khanna M, Bortnov V, Annis DS, Nguyen CL, Mosher DF., Clin Exp Allergy 47(10), 2017
PMID: 28378503
miR-720 is a downstream target of an ADAM8-induced ERK signaling cascade that promotes the migratory and invasive phenotype of triple-negative breast cancer cells.
Das SG, Romagnoli M, Mineva ND, Barillé-Nion S, Jézéquel P, Campone M, Sonenshein GE., Breast Cancer Res 18(1), 2016
PMID: 27039296
Processing of Snake Venom Metalloproteinases: Generation of Toxin Diversity and Enzyme Inactivation.
Moura-da-Silva AM, Almeida MT, Portes-Junior JA, Nicolau CA, Gomes-Neto F, Valente RH., Toxins (Basel) 8(6), 2016
PMID: 27294958
A novel peptide ADAM8 inhibitor attenuates bronchial hyperresponsiveness and Th2 cytokine mediated inflammation of murine asthmatic models.
Chen J, Deng L, Dreymüller D, Jiang X, Long J, Duan Y, Wang Y, Luo M, Lin F, Mao L, Müller B, Koller G, Bartsch JW., Sci Rep 6(), 2016
PMID: 27458083
ADAM-family metalloproteinases in lung inflammation: potential therapeutic targets.
Dreymueller D, Uhlig S, Ludwig A., Am J Physiol Lung Cell Mol Physiol 308(4), 2015
PMID: 25480335
ADAM8 as a drug target in pancreatic cancer.
Schlomann U, Koller G, Conrad C, Ferdous T, Golfi P, Garcia AM, Höfling S, Parsons M, Costa P, Soper R, Bossard M, Hagemann T, Roshani R, Sewald N, Ketchem RR, Moss ML, Rasmussen FH, Miller MA, Lauffenburger DA, Tuveson DA, Nimsky C, Bartsch JW., Nat Commun 6(), 2015
PMID: 25629724
ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis.
Romagnoli M, Mineva ND, Polmear M, Conrad C, Srinivasan S, Loussouarn D, Barillé-Nion S, Georgakoudi I, Dagg Á, McDermott EW, Duffy MJ, McGowan PM, Schlomann U, Parsons M, Bartsch JW, Sonenshein GE., EMBO Mol Med 6(2), 2014
PMID: 24375628
Sputum ADAM8 expression is increased in severe asthma and COPD.
Oreo KM, Gibson PG, Simpson JL, Wood LG, McDonald VM, Baines KJ., Clin Exp Allergy 44(3), 2014
PMID: 24147597
N-glycosylation regulates ADAM8 processing and activation.
Srinivasan S, Romagnoli M, Bohm A, Sonenshein GE., J Biol Chem 289(48), 2014
PMID: 25336660
Elevated levels of a disintegrin and metalloproteinase 8 in gingival crevicular fluid of patients with periodontal diseases.
Khongkhunthian S, Techasatian P, Supanchart C, Bandhaya P, Montreekachon P, Thawanaphong S, Krisanaprakornkit S., J Periodontol 84(4), 2013
PMID: 22612366
High expression of ADAM8 correlates with poor prognosis in hepatocellular carcinoma.
Zhang Y, Zha TZ, Hu BS, Jiang C, Ge ZJ, Zhang K, Tan YF., Surgeon 11(2), 2013
PMID: 22878099
High ADAM8 expression is associated with poor prognosis in patients with hepatocellular carcinoma.
Zhang Y, Tan YF, Jiang C, Zhang K, Zha TZ, Zhang M., Pathol Oncol Res 19(1), 2013
PMID: 22965687
Protective effects of ADAM8 against cisplatin-mediated apoptosis in non-small-cell lung cancer.
Zhang W, Wan M, Ma L, Liu X, He J., Cell Biol Int 37(1), 2013
PMID: 23319321
Loss of vps54 function leads to vesicle traffic impairment, protein mis-sorting and embryonic lethality.
Karlsson P, Droce A, Moser JM, Cuhlmann S, Padilla CO, Heimann P, Bartsch JW, Füchtbauer A, Füchtbauer EM, Schmitt-John T., Int J Mol Sci 14(6), 2013
PMID: 23708095
ADAMDEC1 is a metzincin metalloprotease with dampened proteolytic activity.
Lund J, Olsen OH, Sørensen ES, Stennicke HR, Petersen HH, Overgaard MT., J Biol Chem 288(29), 2013
PMID: 23754285
ADAM8 in asthma. Friend or foe to airway inflammation?
Chen J, Jiang X, Duan Y, Long J, Bartsch JW, Deng L., Am J Respir Cell Mol Biol 49(6), 2013
PMID: 23837412
The role of ADAM-mediated shedding in vascular biology.
Dreymueller D, Pruessmeyer J, Groth E, Ludwig A., Eur J Cell Biol 91(6-7), 2012
PMID: 22138087
The role of Adams in Notch signaling.
Groot AJ, Vooijs MA., Adv Exp Med Biol 727(), 2012
PMID: 22399336
Expression of ADAM8 and its clinical values in diagnosis and prognosis of hepatocellular carcinoma.
Jiang C, Zhang Y, Yu HF, Yu XT, Zhou SJ, Tan YF., Tumour Biol 33(6), 2012
PMID: 22941466
Bifunctional role of the Treponema pallidum extracellular matrix binding adhesin Tp0751.
Houston S, Hof R, Francescutti T, Hawkes A, Boulanger MJ, Cameron CE., Infect Immun 79(3), 2011
PMID: 21149586
ADAM-8, a metalloproteinase, drives acute allergen-induced airway inflammation.
Paulissen G, Rocks N, Guéders MM, Bedoret D, Crahay C, Quesada-Calvo F, Hacha J, Bekaert S, Desmet C, Foidart JM, Bureau F, Noel A, Cataldo DD., Eur J Immunol 41(2), 2011
PMID: 21268008
The emerging role of matrix metalloproteases of the ADAM family in male germ cell apoptosis.
Moreno RD, Urriola-Muñoz P, Lagos-Cabré R., Spermatogenesis 1(3), 2011
PMID: 22319668
The murine goblet cell protein mCLCA3 is a zinc-dependent metalloprotease with autoproteolytic activity.
Bothe MK, Mundhenk L, Kaup M, Weise C, Gruber AD., Mol Cells 32(6), 2011
PMID: 22080371
Regulating inflammation: ADAM8--a new player in the game.
Zarbock A, Rossaint J., Eur J Immunol 41(12), 2011
PMID: 22125009
The metalloprotease ADAM8 is associated with and regulates the function of the adhesion receptor PSGL-1 through ERM proteins.
Domínguez-Luis M, Lamana A, Vazquez J, García-Navas R, Mollinedo F, Sánchez-Madrid F, Díaz-González F, Urzainqui A., Eur J Immunol 41(12), 2011
PMID: 22229154
ADAM8 is a negative regulator of retinal neovascularization and of the growth of heterotopically injected tumor cells in mice.
Guaiquil VH, Swendeman S, Zhou W, Guaiquil P, Weskamp G, Bartsch JW, Blobel CP., J Mol Med (Berl) 88(5), 2010
PMID: 20119708
The metalloprotease-disintegrin ADAM8 is essential for the development of experimental asthma.
Naus S, Blanchet MR, Gossens K, Zaph C, Bartsch JW, McNagny KM, Ziltener HJ., Am J Respir Crit Care Med 181(12), 2010
PMID: 20194813
Novel alternatively spliced ADAM8 isoforms contribute to the aggressive bone metastatic phenotype of lung cancer.
Hernández I, Moreno JL, Zandueta C, Montuenga L, Lecanda F., Oncogene 29(26), 2010
PMID: 20453887
Deficiency of the metalloproteinase-disintegrin ADAM8 is associated with thymic hyper-cellularity.
Gossens K, Naus S, Holländer GA, Ziltener HJ., PLoS One 5(9), 2010
PMID: 20856819
ADAM8 is selectively up-regulated in endothelial cells and is associated with angiogenesis after spinal cord injury in adult mice.
Mahoney ET, Benton RL, Maddie MA, Whittemore SR, Hagg T., J Comp Neurol 512(2), 2009
PMID: 19003792
ADAM8 and its single nucleotide polymorphism 2662 T/G are associated with advanced atherosclerosis and fatal myocardial infarction: Tampere vascular study.
Levula M, Airla N, Oksala N, Hernesniemi JA, Pelto-Huikko M, Salenius JP, Zeitlin R, Järvinen O, Huovila AP, Nikkari ST, Jaakkola O, Ilveskoski E, Mikkelsson J, Perola M, Laaksonen R, Kytömäki L, Soini JT, Kähönen M, Parkkinen J, Karhunen PJ, Lehtimäki T., Ann Med 41(7), 2009
PMID: 19575316
ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the gamma-secretase.
Tousseyn T, Thathiah A, Jorissen E, Raemaekers T, Konietzko U, Reiss K, Maes E, Snellinx A, Serneels L, Nyabi O, Annaert W, Saftig P, Hartmann D, De Strooper B., J Biol Chem 284(17), 2009
PMID: 19213735
Characterization of the catalytic activity of the membrane-anchored metalloproteinase ADAM15 in cell-based assays.
Maretzky T, Yang G, Ouerfelli O, Overall CM, Worpenberg S, Hassiepen U, Eder J, Blobel CP., Biochem J 420(1), 2009
PMID: 19207106
ADAM8: a new therapeutic target for asthma.
Knolle MD, Owen CA., Expert Opin Ther Targets 13(5), 2009
PMID: 19397475
Reduced incidence and severity of experimental autoimmune arthritis in mice expressing catalytically inactive A disintegrin and metalloproteinase 8 (ADAM8).
Zack MD, Melton MA, Stock JL, Storer CE, Barve RA, Minnerly JC, Weiss DJ, Stejskal JA, Tortorella MD, Turk JR, Shevlin KM, Malfait AM., Clin Exp Immunol 158(2), 2009
PMID: 19737139
ADAM-8 isolated from human osteoarthritic chondrocytes cleaves fibronectin at Ala(271).
Zack MD, Malfait AM, Skepner AP, Yates MP, Griggs DW, Hall T, Hills RL, Alston JT, Nemirovskiy OV, Radabaugh MR, Leone JW, Arner EC, Tortorella MD., Arthritis Rheum 60(9), 2009
PMID: 19714641
ADAM8 substrate specificity: influence of pH on pre-processing and proteoglycan degradation.
Hall T, Pegg LE, Pauley AM, Fischer HD, Tomasselli AG, Zack MD., Arch Biochem Biophys 491(1-2), 2009
PMID: 19766586
Evolutionary divergence and functions of the ADAM and ADAMTS gene families.
Brocker CN, Vasiliou V, Nebert DW., Hum Genomics 4(1), 2009
PMID: 19951893
Role of ADAM and ADAMTS metalloproteinases in airway diseases.
Paulissen G, Rocks N, Gueders MM, Crahay C, Quesada-Calvo F, Bekaert S, Hacha J, El Hour M, Foidart JM, Noel A, Cataldo DD., Respir Res 10(), 2009
PMID: 20034386
Genome analysis of the platypus reveals unique signatures of evolution.
Warren WC, Hillier LW, Marshall Graves JA, Birney E, Ponting CP, Grützner F, Belov K, Miller W, Clarke L, Chinwalla AT, Yang SP, Heger A, Locke DP, Miethke P, Waters PD, Veyrunes F, Fulton L, Fulton B, Graves T, Wallis J, Puente XS, López-Otín C, Ordóñez GR, Eichler EE, Chen L, Cheng Z, Deakin JE, Alsop A, Thompson K, Kirby P, Papenfuss AT, Wakefield MJ, Olender T, Lancet D, Huttley GA, Smit AF, Pask A, Temple-Smith P, Batzer MA, Walker JA, Konkel MK, Harris RS, Whittington CM, Wong ES, Gemmell NJ, Buschiazzo E, Vargas Jentzsch IM, Merkel A, Schmitz J, Zemann A, Churakov G, Kriegs JO, Brosius J, Murchison EP, Sachidanandam R, Smith C, Hannon GJ, Tsend-Ayush E, McMillan D, Attenborough R, Rens W, Ferguson-Smith M, Lefèvre CM, Sharp JA, Nicholas KR, Ray DA, Kube M, Reinhardt R, Pringle TH, Taylor J, Jones RC, Nixon B, Dacheux JL, Niwa H, Sekita Y, Huang X, Stark A, Kheradpour P, Kellis M, Flicek P, Chen Y, Webber C, Hardison R, Nelson J, Hallsworth-Pepin K, Delehaunty K, Markovic C, Minx P, Feng Y, Kremitzki C, Mitreva M, Glasscock J, Wylie T, Wohldmann P, Thiru P, Nhan MN, Pohl CS, Smith SM, Hou S, Nefedov M, de Jong PJ, Renfree MB, Mardis ER, Wilson RK., Nature 453(7192), 2008
PMID: 18464734
Elevated soluble ADAM8 in bronchoalveolar lavage fluid in patients with eosinophilic pneumonia.
Matsuno O, Miyazaki E, Nureki S, Ueno T, Ando M, Ito K, Kumamoto T, Higuchi Y., Int Arch Allergy Immunol 142(4), 2007
PMID: 17124430
ADAM8 expression is associated with increased invasiveness and reduced patient survival in pancreatic cancer.
Valkovskaya N, Kayed H, Felix K, Hartmann D, Giese NA, Osinsky SP, Friess H, Kleeff J., J Cell Mol Med 11(5), 2007
PMID: 17979891
Identification of candidate substrates for ectodomain shedding by the metalloprotease-disintegrin ADAM8.
Naus S, Reipschläger S, Wildeboer D, Lichtenthaler SF, Mitterreiter S, Guan Z, Moss ML, Bartsch JW., Biol Chem 387(3), 2006
PMID: 16542157
(Make) stick and cut loose--disintegrin metalloproteases in development and disease.
Tousseyn T, Jorissen E, Reiss K, Hartmann D., Birth Defects Res C Embryo Today 78(1), 2006
PMID: 16622847
Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors.
Sanderson MP, Dempsey PJ, Dunbar AJ., Growth Factors 24(2), 2006
PMID: 16801132
Implication of ADAM-8, -9, -10, -12, -15, -17, and ADAMTS-1 in implantational remodeling of a mouse uterus.
Kim J, Kang SG, Kim JI, Park JH, Kim SK, Cho DJ, Kim H., Yonsei Med J 47(4), 2006
PMID: 16941747
ADAM8 expression in prostate cancer is associated with parameters of unfavorable prognosis.
Fritzsche FR, Jung M, Xu C, Rabien A, Schicktanz H, Stephan C, Dietel M, Jung K, Kristiansen G., Virchows Arch 449(6), 2006
PMID: 17106710
Metalloprotease-disintegrin ADAM8: expression analysis and targeted deletion in mice.
Kelly K, Hutchinson G, Nebenius-Oosthuizen D, Smith AJ, Bartsch JW, Horiuchi K, Rittger A, Manova K, Docherty AJ, Blobel CP., Dev Dyn 232(1), 2005
PMID: 15580619
ADAMs: key components in EGFR signalling and development.
Blobel CP., Nat Rev Mol Cell Biol 6(1), 2005
PMID: 15688065
Two separate metalloproteinase activities are responsible for the shedding and processing of the NG2 proteoglycan in vitro.
Asher RA, Morgenstern DA, Properzi F, Nishiyama A, Levine JM, Fawcett JW., Mol Cell Neurosci 29(1), 2005
PMID: 15866049
The facial motor nucleus transcriptional program in response to peripheral nerve injury identifies Hn1 as a regeneration-associated gene.
Zujovic V, Luo D, Baker HV, Lopez MC, Miller KR, Streit WJ, Harrison JK., J Neurosci Res 82(5), 2005
PMID: 16267826
Mouse ADAM33: two splice variants differ in protein maturation and localization.
Umland SP, Wan Y, Shah H, Garlisi CG, Devito KE, Braunschweiger K, Gheyas F, Del Mastro R., Am J Respir Cell Mol Biol 30(4), 2004
PMID: 12972401
Catalytic activity of human ADAM33.
Zou J, Zhu F, Liu J, Wang W, Zhang R, Garlisi CG, Liu YH, Wang S, Shah H, Wan Y, Umland SP., J Biol Chem 279(11), 2004
PMID: 14676211
ADAM proteins in the brain.
Novak U., J Clin Neurosci 11(3), 2004
PMID: 14975408
Novel metalloprotease-disintegrin, meltrin epsilon (ADAM35), expressed in epithelial tissues during chick embryogenesis.
Watabe-Uchida M, Masuda A, Shimada N, Endo M, Shimamura K, Yasuda K, Sehara-Fujisawa A., Dev Dyn 230(3), 2004
PMID: 15188440
ADAM23 is a cell-surface glycoprotein expressed by central nervous system neurons.
Goldsmith AP, Gossage SJ, ffrench-Constant C., J Neurosci Res 78(5), 2004
PMID: 15505805
Identification of genes that are induced after cadmium exposure by suppression subtractive hybridization.
Shin HJ, Park KK, Lee BH, Moon CK, Lee MO., Toxicology 191(2-3), 2003
PMID: 12965115

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 12372841
PubMed | Europe PMC

Suchen in

Google Scholar